Dr. (Prof.) Atul Sharma

MBBS, MD (Medicine), DM (Medical Oncology)

Vice Chairman – Max Network Medical Oncology

28+ Years of Experience
Delhi NCR

Dr. (Prof.) Atul Sharma is an exceptionally brilliant, globally renowned leader in the field of Medical Oncology and Cancer Therapeutics. Prior to joining Max Saket as Vice Chairman, Dr. Sharma served with profound distinction as a senior Professor of Medical Oncology at the premier apex medical center of India, the All India Institute of Medical Sciences (AIIMS, New Delhi). He represents the absolute peak tier of evidence-based cancer management and personalized oncology in South Asia. He is widely sought after by a vast international patient base for his elite expertise in formulating highly advanced chemotherapy lines, precision target-oriented therapies, and cutting-edge cancer immunotherapies. Known for his deeply intellectual mind, articulate communication, and profoundly empathetic care lines, he designs comprehensive cancer-warrior pathways that maximize survival indices while preserving daily physical functionality.

  • Solid Tumor Oncology: Advanced medical protocols and biological targeted lines for lung cancers, breast malignancies, head and neck tumors, and gastrointestinal cancers.

  • Precision Cancer Immunotherapy: Deploying modern checkpoint inhibitors and immune-modulators to train the body’s natural cells to target aggressive malignancies.

  • Hematological Malignancies: Formulating intensive multi-drug chemotherapy regimens to treat acute leukemias, Hodgkin’s and non-Hodgkin’s lymphomas, and multiple myelomas.

  • Personalized Targeted Therapies: Utilizing advanced genetic and molecular profiling of tumors to intercept cancer growth pathways at a cellular level.
  • Successfully guided tens of thousands of cancer warriors through complex, intense curative systemic therapeutic journeys with world-class survival outcomes.

  • Played a monumental, central role in designing and leading dozens of landmark clinical trials evaluating the safety of novel cancer medications in South Asia.

  • Prolific academic leader who has published over 120 research papers in high-impact international oncology journals and mentored a generation of oncologists.
  • Conferred with multiple prestigious clinical excellence honors and “Oncologist of the Year” accolades by premier national oncology assemblies.

  • Active member of elite global bodies including the American Society of Clinical Oncology (ASCO) and the European Society for Medical Oncology (ESMO).